All In MedTech

Device Trial Radar · NCT07078422

Home Use Study of Targeted Mechanical Stimulation for Tremor Relief

Last checked: Nov 19, 2026Latest source record: Nov 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Jan 1, 2025

Primary completion

Dec 2025

Study completion Jun 2026

Sponsor

Lead sponsor
Encora, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 22, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Subjects will receive prototype devices to be used for participation. The study comprises three phases: 1. Alpha phase: Two remote study visits and an in-home period to gather device usability data on the alpha system. The at home period for this phase will be 2 weeks. This phase will be used to confirm that the device and labeling are suitable for in-home use. 2. Beta Phase B1: Beta Phase B1 will be conducted using the beta devices for two in-person or remote, 60 to 90-minute, visits. This phase will be used to assess design changes between alpha and beta versions. 3. Beta Phase B2: Seven remote visits and in-home usage to gather usability and efficacy data on the beta system in-home. Beta Phase B2 will be conducted using the beta devices for 12 weeks. This phase will be used to assess design changes between alpha and beta versions.

Conditions

  • Essential Tremor
  • Parkinson's Disease

Interventions

  • Encora PulseDevice

    The proposed therapeutic device is a wristband that delivers personalized therapeutic relief to users by adjusting parameters of mechanical vibration, tailored to each individual user's tremor. It measures and characterizes users' upper limb tremor before determining what parameters of mechanical vibration should be applied to stimulate the sensory neurons on the wrist. This study will not be conducted under IDE. It is a non-significant risk due to the non-invasive nature of mechanical vibration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assess the design changes between the alpha and beta versions of the deviceTime frame: Data will be collected at baseline and visit one.
  2. To assess the usability of the beta device in an at-home settingTime frame: Data will be collected at baseline, week 1, week 2, month 1, month 2 and month 3.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Encora Therapeutics

    Cambridge, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.